Dennis Phillip Andrewinsider trades
In SEC Form 4 filings, Dennis Phillip Andrew is listed as Chief Medical Officer of NovaBridge Biosciences (NBP). In the last 90 days, Dennis Phillip Andrew sold $5.8K of NovaBridge Biosciences (NBP) on the open market and bought none.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| NBPNovaBridge Biosciences | Chief Medical Officer | 3 | Sep 21 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-21
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| NBPNovaBridge Biosciences | Sep 18 | Sep 21 | S | 8,209 | $0.71 | Sale −$5,828 | 173,427 | No | Form 4 |
| NBPNovaBridge Biosciences | Sep 17 | Sep 21 | M | 23,695 | not reported | not reported | 181,636 | No | Form 4 |
| NBPNovaBridge Biosciences | Sep 17 | Sep 21 | M · derivative | 10,302 | $0.00 | $0 | 72,120 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.